Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Diarylquinolines target subunit c of mycobacterial ATP synthase

Nature Chemical Biology volume 3, pages 323–324 (2007)Cite this article

Abstract

The diarylquinoline R207910 (TMC207) is a promising candidate in clinical development for the treatment of tuberculosis. Though R207910-resistant mycobacteria bear mutations in ATP synthase, the compound's precise target is not known. Here we establish by genetic, biochemical and binding assays that the oligomeric subunit c (AtpE) of ATP synthase is the target of R207910. Thus targeting energy metabolism is a new, promising approach for antibacterial drug discovery.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: ATP synthase subunit composition and inhibition by R207910.
Figure 2: Binding studies using compound-linked affinity chromatography and BIAcore.

References

  1. Dye, C., Scheele, S., Dolin, P., Pathania, V. & Raviglione, M.C. J. Am. Med. Assoc. 282, 677–686 (1999).

    Article  CAS  Google Scholar 

  2. Andries, K. et al. Science 307, 223–227 (2005).

    Article  CAS  Google Scholar 

  3. Ji, B. et al. Antimicrob. Agents Chemother. 50, 1921–1926 (2006).

    Article  CAS  Google Scholar 

  4. Junge, W. & Nelson, N. Science 308, 642–644 (2005).

    Article  CAS  Google Scholar 

  5. Walsh, C. Nature 406, 775–781 (2000).

    Article  CAS  Google Scholar 

  6. Telenti, A. et al. J. Clin. Microbiol. 35, 719–723 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. de Jonge, M.R., Koymans, L.H., Guillemont, J.E., Koul, A. & Andries, K. Proteins published online 23 March 2007 (doi:10.1002/prot.21376).

    Article  CAS  Google Scholar 

  8. Telenti, A. et al. Nat. Med. 3, 567–570 (1997).

    Article  CAS  Google Scholar 

  9. Wang, R., Prince, J.T. & Marcotte, E.M. Genome Res. 15, 1118–1126 (2005).

    Article  CAS  Google Scholar 

  10. Tran, S.L. & Cook, G.M. J. Bacteriol. 187, 5023–5028 (2005).

    Article  CAS  Google Scholar 

  11. Ferrandiz, M.J. & de la Campa, A.G. FEMS Microbiol. Lett. 212, 133–138 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank P. Janssens, T. Gevers, H. Szel, J. Hendrickx, A. Shanmugham, E. Pasquier, A. Poncelet, P. Palandjian, S. Masure, W. Bruinzeel and P. Verhasselt for technical help; N. Lounis, L. Geeraert and M. Haxaire-Theeuwes for critical reading; E. Mortz (Alphalyse, Denmark) for mass spectrometry analysis; H. Van Vlijmen for R207910-docking figure; L. Leijssen for help with figures; and Vichem (Budapest) for coupling experiments. Z.R., H.L. and D.B. acknowledge EU financial support (Marie-Curie MRTN-CT-2005-019481).

Author information

Author notes

  1. Anil Koul and Najoua Dendouga: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, Beerse, B-2340, Belgium

    Anil Koul, Najoua Dendouga, Karen Vergauwen, Brenda Molenberghs, Luc Vranckx, Rudy Willebrords & Koen Andries

  2. Department of Structural Biology, Institute of Molecular Cell Biology, Vrije Universiteit Amsterdam, De Boelelaan 1085, Amsterdam, 1081HV, The Netherlands

    Zorica Ristic, Holger Lill & Dirk Bald

  3. Pharmaceutical Research & Development, Johnson & Johnson, Campus de Maigremont-BP615, Val de Reuil Cedex, F-27106, France

    Ismet Dorange & Jerome Guillemont

Authors
  1. Anil Koul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Najoua Dendouga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen Vergauwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brenda Molenberghs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luc Vranckx
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rudy Willebrords
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zorica Ristic
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Holger Lill
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ismet Dorange
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jerome Guillemont
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Dirk Bald
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Koen Andries
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

A.K. wrote the manuscript as a project team leader, with contributions from K.A., D.B. and N.D. A.K., K.A., N.D. and D.B. contributed to study design and data analysis. K.V. did ATP synthesis assay; N.D. made constructs for subunit c purification; N.D. and B.M. did affinity chromatography assays and complementation studies; R.W. contributed to DARQ screening; L.V. did ATP measurements, MIC determinations and isolation of resistant mutants; J.G. and I.D. synthesized DARQs, separated isomers and performed chemical characterizations; and H.L. and Z.R. contributed to the BIAcore binding experiments.

Corresponding author

Correspondence to Anil Koul.

Ethics declarations

Competing interests

Research for this project is mainly provided by Johnson & Johnson Pharmaceuticals. A.K., N.D., K.V., B.M., L.V., R.W., I.D., J.G and K.A. are employees of Johnson & Johnson.

Supplementary information

Supplementary Fig. 1

Chemical structure of R207910 (R,S) and related isomers. (PDF 19 kb)

Supplementary Fig. 2

Genetic organization of mycobacterial ATP synthase and homology model of subunit-c. (PDF 96 kb)

Supplementary Fig. 3

Characterization of R207910-resistant M. tuberculosis strains. (PDF 27 kb)

Supplementary Fig. 4

Binding studies using affinity capture chromatography. (PDF 76 kb)

Supplementary Fig. 5

BIAcore interaction analysis of purified whole ATP synthase from Bacillus PS3 or its α3β3γ sub-complex with R207910. (PDF 46 kb)

Supplementary Table 1

MICs of R207910 stereoisomers in different mycobacterial species. (PDF 44 kb)

Supplementary Table 2

Inhibition of M. smegmatis ATP synthase activity by DARQ compounds. (PDF 18 kb)

Supplementary Methods (PDF 158 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Koul, A., Dendouga, N., Vergauwen, K. et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 3, 323–324 (2007). https://doi.org/10.1038/nchembio884

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio884

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing